Patients Coming Off Anti-Obesity Injections Regain Pounds at a Quadrupled Rate Compared to Dieters
New research suggests that patients who stop using popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt conventional lifestyle plans.
Research printed in a leading health publication shows that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals buying such medications need to be aware of the potential of quick weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment mass in about one and a half years.
Comparing Approaches
The research, which looked at 37 of trials involving thousands of patients, contrasted the results of the injectable medications with other pills.
Scientists emphasize that people who lose weight through dieting usually have a less rapid creep back—around 0.1 kg a month—post-intervention.
Explaining the Fast Regain
Experts believe the way of the drugs is key to understanding the amplified regain.
These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Artificially providing GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication leads to appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Disease?
Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts say that, given the likelihood of weight regain, the therapy should be considered life-long.
This perspective is reinforced by pharmaceutical companies, who say that the results "highlight the long-term nature of obesity," akin to managing conditions like high blood pressure.
User Accounts
People who have discontinued the jabs report a intense resurgence of appetite.
"It was like something that goes on and I was suddenly ravenous," described a patient.
The struggle is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy.
Growing Use
Survey data indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are powerful tools for weight loss, they are not a standalone cure and maintained weight loss relies on ongoing behavioural management.
